FDA inspection
Novartis Grimsby Limited: FDA inspection ending Sep 13, 2019
FDA inspection 1107055 · No Action Indicated (NAI) · Grimsby
Key facts
| Inspection ID | 1107055 |
|---|---|
| Firm | Novartis Grimsby Limited |
| FEI number | 10656 |
| Address | Ne Lincolnshire, Moody Lane; Pyewipe |
| City | Grimsby |
| Country | United Kingdom |
| Fiscal year | 2019 |
| Inspection end date | Sep 13, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data